Basic Information
Triclinium is a full-service South African CRO and a subsidiary of EOH, one of the largest technology services companies in Africa. Triclinium has secured contracts from large pharmaceutical companies and small biotechnology firms across various therapeutic areas, including ID studies such as malaria and HIV, and has a long history and specialized expertise in tuberculosis trials. The current studies in TCD's portfolio include innovative vaccines and therapies, covering all phases of clinical research, from single-dose Phase I trials to large, multi-site Phase III and IV trials.
Triclinium Clinical Development Proprietary Limited
South Africa
101~500 people
January 01, 2000
--
info@tcd-global.com

